Last reviewed · How we verify
NCT05341687: COMPLIECMO
Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
trial testing No applicable in Ards in 122 participants. Completed in 1 May 2023.
31 December 2021
Quick facts
| Lead sponsor | Central Hospital, Nancy, France |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 122 |
| Start date | 3 January 2020 |
| Primary completion | 31 December 2021 |
| Estimated completion | 1 May 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- No applicable
Conditions studied
- Ards — all drugs for Ards →
- Mechanical Ventilation Pressure High — all drugs for Mechanical Ventilation Pressure High →
- Extracorporeal Membrane Oxygenation — all drugs for Extracorporeal Membrane Oxygenation →
Sponsor
Central Hospital, Nancy, France
Who can join
18 and older, any sex, with Ards or Mechanical Ventilation Pressure High. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mortality of patients with COVID-19 associated acute respiratory distress syndrome (CARDS) treated with veno-venous extra-corporal membrane oxygenation (vv-ECMO) is increasing over time since the beginning of the COVID-19 pandemic. The objectives were to retrospectively describe over the first ten days after vv-ECMO implantation, the ventilatory management of CARDS and to assess the impact of static respiratory system compliance (CRS) on the first day of vv-ECMO on 180-day mortality.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prognostic value of respiratory compliance course on mortality in COVID-19 patients with vv-ECMO.
Valentin S, Amalric M, Granier G, Pequignot B, et al · · 2023 · cited 9× · PMID 37341800 · DOI 10.1186/s13613-023-01152-7
Verify or expand the search:
- PubMed search for NCT05341687
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ards
Currently open trials in the same condition.
- NCT07100860 — The Effect of Single Lung Ventilation Duration on Postoperative Pulmonary Complications in Thoracic Surgery · recruiting
- NCT06513299 — Effectiveness of Low Volume and Low Pressure in Severe Hypoxemic Patients · active not recruiting
Other Central Hospital, Nancy, France trials
Trials by the same sponsor.
- NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
- NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
- NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
- NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
- NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05341687 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
- Last refreshed: 17 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05341687.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing